Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Non-Current Deffered Revenue (2016 - 2023)

Pulmatrix's Non-Current Deffered Revenue history spans 9 years, with the latest figure at $3.7 million for Q4 2023.

  • For Q4 2023, Non-Current Deffered Revenue fell 22.71% year-over-year to $3.7 million; the TTM value through Dec 2023 reached $3.7 million, down 22.71%, while the annual FY2023 figure was $3.7 million, 22.71% down from the prior year.
  • Non-Current Deffered Revenue for Q4 2023 was $3.7 million at Pulmatrix, down from $4.0 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $8.0 million in Q3 2020 and bottomed at $3.7 million in Q4 2023.
  • The 5-year median for Non-Current Deffered Revenue is $5.4 million (2021), against an average of $5.6 million.
  • The largest annual shift saw Non-Current Deffered Revenue skyrocketed 9558.21% in 2019 before it tumbled 32.14% in 2021.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $7.9 million in 2019, then dropped by 21.72% to $6.2 million in 2020, then decreased by 1.61% to $6.1 million in 2021, then dropped by 20.55% to $4.8 million in 2022, then fell by 22.71% to $3.7 million in 2023.
  • Per Business Quant, the three most recent readings for PULM's Non-Current Deffered Revenue are $3.7 million (Q4 2023), $4.0 million (Q3 2023), and $4.3 million (Q2 2023).